Literature DB >> 16961295

Modulation of matrix metalloproteinase and TIMP-1 expression by TGF-beta1 in cultured human RPE cells.

Aiping Zeng1, Shuiqing Zeng, Yang Cheng, Qing Xiao.   

Abstract

In order to investigate the effects of TGF-beta1 on the expression of MMP-2, -9 and TIMP-1 in human retinal pigment epithelial (RPE) cells, the third-sixth passage cultured RPE cells were treated with TGF-beta1 at different concentrations (0.01, 0.1, 1.0, 10 ng/mL), the expression of MMP-2, -9 and TIMP-1 mRNA was detected by semi-quantitative RT-PCR assays. MMP-2, -9 and TIMP-1 mRNA were expressed in the cultured RPE cells. The values of MMP-2/beta-actin in the cells treated with 0.1, 1.0, 10 ng/mL TGF-beta1 were 1.04 +/- 0.04, 1.07 +/- 0.02 and 1.11 +/- 0.03, respectively, significantly higher than in the control group (0.96 +/- 0.03, P < 0.05-0.01). The expression of MMP-2 mRNA could be up-regulated by TGF-beta1, in a dose-dependent manner. The expression of MMP-9 mRNA in the cultured RPE cells was slightly up-regulated by various TGF-beta1 concentrations treatment. The values of TIMP-1/beta-actin in the cells treated with 0.01 and 0.1 ng/ mL TGF-beta1 were 0.85 +/- 0.01 and 0.97 +/- 0.02 respectively, significantly lower than in the control group (1.07 +/- 0.04, P < 0.01), indicating that the expression of TIMP-1 mRNA was down-regulated by TGF-beta1 at low concentrations. But along with the increase of TGF-beta1 concentrations (1.0 and 10 ng/mL), the expression of TIMP-1 mRNA was slightly up-regulated, not significantly different from that in the control group (P > 0.05). It was concluded that TGF-beta1 might play an important role in the up-regulation of the expression of MMP-2 in RPE cells and result in a directional shift in the balance between MMP and TIMP. This may be facilitated for RPE cells to migrate in the pathogenesis of vitreoretinopathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961295     DOI: 10.1007/bf02829577

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

Review 1.  Tissue inhibitors of metalloproteinases: evolution, structure and function.

Authors:  K Brew; D Dinakarpandian; H Nagase
Journal:  Biochim Biophys Acta       Date:  2000-03-07

Review 2.  Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration.

Authors:  P Wiedemann
Journal:  Surv Ophthalmol       Date:  1992 Mar-Apr       Impact factor: 6.048

Review 3.  Matrix and the retinal pigment epithelium in proliferative retinal disease.

Authors:  P Hiscott; C Sheridan; R M Magee; I Grierson
Journal:  Prog Retin Eye Res       Date:  1999-03       Impact factor: 21.198

4.  Regulation of MMP-9 production by human corneal epithelial cells.

Authors:  D Q Li; B L Lokeshwar; A Solomon; D Monroy; Z Ji; S C Pflugfelder
Journal:  Exp Eye Res       Date:  2001-10       Impact factor: 3.467

5.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.

Authors:  L C Padgett; G M Lui; Z Werb; M M LaVail
Journal:  Exp Eye Res       Date:  1997-06       Impact factor: 3.467

6.  Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels.

Authors:  R C Hunt; A Fox; V al Pakalnis; M M Sigel; W Kosnosky; P Choudhury; E P Black
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-10       Impact factor: 4.799

  6 in total
  1 in total

1.  Expression of transforming growth factor β and matrix metalloproteinases in the aqueous humor of patients with congenital ectopia lentis.

Authors:  Qianzhong Cao; Bing Xiao; Guangming Jin; Jianqiang Lin; Yiyao Wang; Charlotte Aimee Young; Junxiong Lin; Yijing Zhou; Bo Zhang; Mingzhe Cao; Kaili Wu; Danying Zheng
Journal:  Mol Med Rep       Date:  2019-05-23       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.